MUTATION OF ABCA4 GENE AS A CAUSE OF AUTOSOMAL RECESSIVE FORM OF STARGARDT DISEASE - CASE REPORT

Authors

  • Angelka Spirkoska Mageroska PHI General Hospital with extended activity, Prilep, Republic of North Macedonia
  • Stefan Pandilov University Clinic for Eye Diseases, Skopje, Republic of North Macedonia
  • Natasha Trpevska Shekerinov University Clinic for Eye Diseases, Skopje, Republic of North Macedonia Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Emilija Gjoshevska Dashtevska University Clinic for Eye Diseases, Skopje, Republic of North Macedonia Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Muhamedin Rushiti PHI Clinical Hospital, Tetovo, Republic of North Macedonia
  • Ljelja Muaremoska Kanzoska University Clinic for Pediatric Diseases, Skopje, Republic of North Macedonia
  • Todor Arsov Faculty of Medical Sciences, "Goce Delchev" University, Shtip, Republic of North Macedonia

Keywords:

Stargard disease, autosomal recessive disease, optical coherence tomography, autofluorescence, macular dystrophy

Abstract

Stargardt disease is the most common type of juvenile macular dystrophy. It is inherited autosomal recessively, although autosomal dominant forms have also been described. It affects both sexes equally, without racial predisposition. Patients experience a progressive deterioration of the macular region and loss of central vision, leading to legal blindness in the majority of affected individuals. 

In this paper, we describe the case of an 11-year-old boy who presented for an ophthalmological evaluation due to a progressive decrease in visual acuity. The fundoscopic examination supplemented with imaging ophthalmological methods were sufficient to establish a working diagnosis of Stargardt disease. The diagnosis was confirmed by genetic testing, a mutation of the ABCA4 gene, which is associated with this dystrophy. The importance of this case report is that it is one of the first documented cases of Stargardt disease with ABCA4 mutation in Macedonia.  

References

Tsang SH, Sharma T. Stargardt Disease. Adv Exp Med Biol 2018; 1085: 139-151. doi: 10.1007/978-3-319-95046-4_27.

Stargardt K. Über familiäre, progressive Degeneration in der Maculagegend des Auges. Albrecht von Graefes Archiv für Ophthalmologie 1909; 71: 534-550.

Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology 2003; 110(6): 1151-1158. doi: 10.1016/S0161-6420(03)00333-6.

Vasireddy V, Wong P, Ayyagari R. Genetics and molecular pathology of Stargardt-like macular degeneration. Prog Retin Eye Res 2010; 29(3): 191-207. doi: 10.1016/j. preteyeres. 2010.01.001.

Hadden OB, Gass JD. Fundus flavimaculatus and Stargardt's disease. Am J Ophthalmol 1976; 82(4): 527-39. doi: 10.1016/0002-9394(76)90539-0.

Dean M, Moitra K, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Hum Mutat 2022; 43(9): 1162-1182. doi: 10.1002/humu.24418.

Tsybovsky Y, Molday RS, Palczewski K. The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv Exp Med Biol 2010; 703: 105-125. doi: 10.1007/978-1-4419-5635-4_8.

Al-Khuzaei S, Broadgate S, Foster CR, Shah M, Yu J, Downes SM, et al. An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story. Genes (Basel) 2021; 12(8): 1241. doi: 10.3390/genes12081241.

Fukui T, Yamamoto S, Nakano K, Tsujikawa M, Morimura H, Nishida K, et al. ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002; 43(9): 2819-2824. PMID: 12202497.

Simonelli F, Testa F, Zernant J, Nesti A, Rossi S, Rinaldi E, et al. Association of a homozygous nonsense mutation in the ABCA4 (ABCR) gene with cone-rod dystrophy phenotype in an Italian family. Ophthalmic Res 2004; 36(2): 82-88. doi: 10.1159/000076 886.

Lee W, Zernant J, Nagasaki T, Tsang SH, Allikmets R. Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease. Am J Ophthalmol 2018; 195: 16-25. doi: 10.1016/j.ajo.2018.07.018.

Heath Jeffery RC, Chen FK. Stargardt disease: Multimodal imaging: A review. Clin Exp Ophthalmol 2021; 49(5): 498-515. doi: 10.1111/ceo.13947.

National Center for Biotechnology Information. ClinVar; [VCV000099419.43], https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000099419.43 (accessed June 1, 2024).

Abalem MF, Otte B, Andrews C, Joltikov KA, Branham K, Fahim AT, et al. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence. Am J Ophthalmol 2017; 184: 181-188. doi: 10.1016/j.ajo.2017.10.006.

Uliss AE, Moore AT, Bird AC. The dark choroid in posterior retinal dystrophies. Ophthalmology 1987; 94(11): 1423-1427. doi: 10.1016/s0161-6420(87)33270-1.

Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol 2004; 138(1): 55-63. doi: 10.1016/j.ajo.2004.02.056.

Zahid S, Jayasundera T, Rhoades W, Branham K, Khan N, Niziol LM, et al. Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease. Am J Ophthalmol 2013; 155(3): 465-473.e3. doi: 10.1016/j.ajo.2012.09.011.

Piotter E, McClements ME, MacLaren RE. Therapy Approaches for Stargardt Disease. Biomolecules 2021; 11(8): 1179. doi: 10.3390/biom11081179.

Zhorzholadze NV, Sheremet NL, Tanas AS, Strelnikov VV. Novye vozmozhnosti terapii bolezni Shtargardta [New possibilities in the treatment of Stargardt disease]. Vestn Oftalmol 2020; 136(4. Vyp. 2): 333-343. Russian. doi: 10.17116/oftalma2020136042333.

Downloads

Published

2024-12-11

Issue

Vol. 4 No. 3 (2024): Acad Med J

Section

Case Reports